FDA PMA Approved 🇺🇸 United States

Pulmonary Valve Prosthesis Percutaneously Delivered

PMA: P200015 · Supplement: S072 · Decision Apr 9, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Pulmonary Valve Prosthesis Percutaneously Delivered
Trade Name
Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System
PMA Number
P200015
Supplement Number
S072
Product Code
NPV
Generic Name
Pulmonary valve prosthesis percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
April 9, 2026
Date Received
January 9, 2026
Supplement Type
Real-Time Process
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for updates to the Instructions for Use and Patient Implant Cards related to magnetic resonance imaging safety information (P200015 and P140031) and sizing recommendations for valve-in-valve implantation in a failing INSPIRIS RESILIA aortic valve (P140031 only).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPV Pulmonary Valve Prosthesis Percutaneously Delivered